Advertisement

Topics

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Company Profile

14:58 EST 23rd January 2019 | BioPortfolio


News Articles [1642 Associated News Articles listed on BioPortfolio]

Seattle Genetics, Takeda: Positive ADCETRIS Data From Phase 3 ECHELON-2 Trial

TOKYO (dpa-AFX) - Seattle Genetics, Inc. (SGEN) and Japan's Takeda Pharmaceutical Company Limited announced late Monday positive data from the ECHELON-2 phase 3 clinical trial for ADCETRIS (Brentu...

Seattle Genetics and Takeda report positive data from ECHELON-2 trial

Seattle Genetics and Takeda have reported positive topline results from the Phase II ECHELON-2 trial investigating adcetris (brentuximab vedotin) as...Read More... The post Seattle Genetics and Takeda...

Seattle Genetics and Takeda Announce Positive Phase 3 Results for Adcetris in Frontline CD30-Expressing Peripheral T-Cell Lymphoma

BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that the...

Seattle Genetics Announces Adcetris Approval in Japan for Frontline Hodgkin Lymphoma

NewsSeattle Genetics and Takeda are jointly developing Adcetris.

Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma

Seattle Genetics and its development partner Takeda recently announced stellar Phase III data from its ECHELON-2 clinical trial of Adcetris for peripheral T-cell lymphoma. Clay Siegall, president and ...

ASH: Seattle Genetics, Takeda Show off Data That Secured Latest FDA Approval for Adcetris

Seattle Genetics and Takeda show off the impressive survival data that prompted the FDA to give approval to Adcetris for this indication.

Seattle Genetics begins blood cancer trial with SEA-BCMA

SEA-BCMA is an investigational antibody empowered using Seattle Genetics’ proprietary Sugar Engineered Antibody (SEA) technology designed to enhance antibody dependent cellular cytotoxicity. The tar...

Seattle Genetics completes enrolment in EV-201 trial

Seattle Genetics and Astellas Pharma have completed the enrolment of the first cohort of patients in the EV-201 trial, a...Read More... The post Seattle Genetics completes enrolment in EV-201 trial ap...

Drugs and Medications [441 Associated Drugs and Medications listed on BioPortfolio]

Nesina [Takeda Pharmaceuticals America, Inc.]

These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. App...

Oxygen [Seattle Children's Hospital]

Oxygen

Chlorure de potassium proamp [Laboratoire Aguettant]

Potassium Chloride for Injection Concentrate, USP

Oxygen [Support Medical Company]

Oxygen

Oxygen [Island Equipment Company]

Oxygen

PubMed Articles [1079 Associated PubMed Articles listed on BioPortfolio]

Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Payments from pharmaceutical and device manufacturers to physicians may influence the advice physicians give patients and peers.

Epidemiologic challenges in norovirus vaccine development.

Norovirus is the leading cause of acute gastroenteritis (AGE) worldwide. In the United States norovirus is estimated to cause 19-21 million illnesses, 1.7-1.9 million outpatient visits, 56,000-71,00...

Measles and Rubella Seroprevalence in Mother-Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations.

We sought to compare seroprevalence of protective measles and rubella-specific antibody in mother-infant pairs across two populations: a pre-disease elimination Nepal population with recently introduc...

Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.

To describe the "continuum of care" for hepatitis C virus (HCV) and related health service utilization among persons who inject drugs (PWID) in the Seattle metropolitan area.

A Man (or a Woman) is Known by the Company He/She Keeps.

Clinical Trials [790 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules

The purpose of this study is to assess the BA of 30 or 60 milligram (mg) dexlansoprazole capsule manufactured at TOB (Takeda GmbH Plant Oranienburg) to the corresponding 30 or 60 mg dexlan...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Impact of Non-Commercialism Policy in Seattle Schools

This is a 3-year pilot study funded by National Institute of Health will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on and adopted b...

Companies [3284 Associated Companies listed on BioPortfolio]

Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc.

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to ...

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to ...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc.

More Information about "Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc." on BioPortfolio

We have published hundreds of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record